Date: 2016-01-07
Type of information: Nomination
Compound:
Company: Cellectis (France)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 7, 2016, Cellectis announced the appointment of Dr. Loan Hoang-Sayag to the role of Chief Medical Officer. Dr. Hoang-Sayag’s responsibilities will include bringing the Company's product candidates into clinical stage development, as well as strategic and operational management of all therapeutic activities for Cellectis. Dr. Hoang-Sayag joins Cellectis from Quintiles Transnational, where she was most recently Senior Director of Medical Science.
Dr. Hoang-Sayag is a board-certified physician in hematology and medical oncology with 23 years of experience – eight years in the hospital / university setting and 15 years in oncology clinical development. In her most recent role, she was at Quintiles Transnational for 10 years where she held the positions of Associate Medical Director, Medical Director and Senior Director of Medical Science. Prior to Quintiles, she was at Pierre Fabre Oncology, serving as the oncology project leader in charge of a variety of clinical studies for this France-based pharmaceutical company. Additionally, Dr. HoangSayag was a medical manager at Hoffmann La Roche in France where she was responsible for
clinical development and medical affairs activities for several new oncology drugs. Dr. Hoang-Sayag will report to Mathieu Simon, MD, Executive Vice President and Chief Operating Officer of Cellectis.
Financial terms:
Latest news:
